Location: Greenwich, CT
CIK: 0001596452 · Show all filings
Period: Q4 2020 (← Previous) (Next →)
Filing Date: Feb 16, 2021
Total Value: $245M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 65,000 | $10.23M | 4.2% | $157.38 * | $125.77 | +8.6% | Cash Securities | 478160104 |
| HCA | HCA Healthcare Inc | 60,000 | $9.868M | 4.0% | $164.47 * | $120.02 | +31.2% | Cash Securities | 40412C101 |
| REGN | Regeneron Pharmaceuticals Inc | 20,000 | $9.662M | 3.9% | $483.10 | $482.26 | -0.4% | Cash Securities | 75886F107 |
| MCK | McKesson Corp | 55,000 | $9.566M | 3.9% | $173.93 * | $143.93 | +17.3% | Cash Securities | 58155Q103 |
| MDT | Medtronic PLC | 80,000 | $9.371M | 3.8% | $117.14 * | $84.01 | +21.0% | Cash Securities | G5960L103 |
| ZBH | Zimmer Biomet Holdings Inc | 60,000 | $9.245M | 3.8% | $154.08 * | $126.70 | +13.3% | Cash Securities | 98956P102 |
| UHS | Universal Health Services Inc | 65,000 | $8.938M | 3.6% | $137.51 * | $104.18 | +28.6% | Cash Securities | 913903100 |
| DHR | Danaher Corp | 40,000 | $8.886M | 3.6% | $222.15 * | $115.08 | +67.4% | Cash Securities | 235851102 |
| ABT | Abbott Laboratories | 75,000 | $8.212M | 3.3% | $109.49 * | $79.63 | +25.6% | Cash Securities | 002824100 |
| IQV | IQVIA Holdings Inc | 45,000 | $8.063M | 3.3% | $179.18 | $160.64 | +11.5% | Cash Securities | 46266C105 |
| SYK | Stryker Corp | 30,000 | $7.351M | 3.0% | $245.03 * | $173.69 | +34.0% | Cash Securities | 863667101 |
| BSX | Boston Scientific Corp | 200,000 | $7.19M | 2.9% | $35.95 | $38.16 | -5.8% | Cash Securities | 101137107 |
| HUM | Humana Inc | 17,500 | $7.18M | 2.9% | $410.29 * | $283.27 | +38.3% | Cash Securities | 444859102 |
| AVTR | Avantor Inc | 250,000 | $7.038M | 2.9% | $28.15 | $17.63 | +59.6% | Cash Securities | 05352A100 |
| BMRN | BioMarin Pharmaceutical Inc | 80,000 | $7.015M | 2.9% | $87.69 | $83.54 | +5.0% | Cash Securities | 09061G101 |
| UNH | UnitedHealth Group Inc | 20,000 | $7.014M | 2.9% | $350.70 * | $281.21 | +14.9% | Cash Securities | 91324P102 |
| TMO | Thermo Fisher Scientific Inc | 15,000 | $6.987M | 2.8% | $465.80 | $297.98 | +54.3% | Cash Securities | 883556102 |
| MOH | Molina Healthcare Inc | 32,500 | $6.912M | 2.8% | $212.68 | $175.22 | +21.4% | Cash Securities | 60855R100 |
| BDX | Becton Dickinson and Co | 27,500 | $6.881M | 2.8% | $250.22 * | $217.92 | +3.4% | Cash Securities | 075887109 |
| THC | Tenet Healthcare Corp | 170,000 | $6.788M | 2.8% | $39.93 | $32.27 | +23.7% | Cash Securities | 88033G407 |
| — | Laboratory Corp of America Ho | 32,500 | $6.615M | 2.7% | $203.54 | $166.12 | — | Cash Securities | 50540R409 |
| ELV | Anthem Inc | 20,000 | $6.422M | 2.6% | $321.10 * | $286.17 | +4.8% | Cash Securities | 036752103 |
| BAX | Baxter International Inc | 75,000 | $6.018M | 2.5% | $80.24 * | $75.21 | -4.1% | Cash Securities | 071813109 |
| LLY | Eli Lilly and Co | 35,000 | $5.909M | 2.4% | $168.83 * | $145.78 | +9.9% | Cash Securities | 532457108 |
| GH | Guardant Health Inc | 45,000 | $5.8M | 2.4% | $128.89 | $96.72 | +33.3% | Cash Securities | 40131M109 |
| — | Catalent Inc | 55,000 | $5.724M | 2.3% | $104.07 | $85.66 | — | Cash Securities | 148806102 |
| CAH | Cardinal Health Inc | 100,000 | $5.356M | 2.2% | $53.56 * | $45.57 | +4.2% | Cash Securities | 14149Y108 |
| INCY | Incyte Corp | 60,000 | $5.219M | 2.1% | $86.98 | $86.51 | +0.5% | Cash Securities | 45337C102 |
| CRL | Charles River Laboratories In | 20,000 | $4.997M | 2.0% | $249.85 | $207.53 | +20.4% | Cash Securities | 159864107 |
| BIO | Bio-Rad Laboratories Inc | 8,000 | $4.664M | 1.9% | $583.00 | $510.44 | +14.2% | Cash Securities | 090572207 |
| GRFS | Grifols SA | 250,000 | $4.61M | 1.9% | $18.44 | $18.53 | -0.5% | Cash Securities | 398438408 |
| ELAN | Elanco Animal Health Inc | 150,000 | $4.601M | 1.9% | $30.67 | $30.51 | +0.5% | Cash Securities | 28414H103 |
| CNC | Centene Corp | 75,000 | $4.502M | 1.8% | $60.03 | $54.65 | +9.8% | Cash Securities | 15135B101 |
| EHC | Encompass Health Corp | 45,000 | $3.721M | 1.5% | $82.69 * | $48.26 | +29.2% | Cash Securities | 29261A100 |
| RGEN | Repligen Corp | 15,000 | $2.874M | 1.2% | $191.60 | $181.94 | +5.3% | Cash Securities | 759916109 |
| ACH | Owens & Minor Inc | 100,000 | $2.705M | 1.1% | $27.05 | $7.31 | +269.9% | Cash Securities | 690732102 |
| NTRA | Natera Inc | 20,000 | $1.99M | 0.8% | $99.50 | $83.55 | +19.1% | Cash Securities | 632307104 |
| ADPT | Adaptive Biotechnologies Corp | 20,000 | $1.183M | 0.5% | $59.15 | $51.56 | +14.7% | Cash Securities | 00650F109 |